SYSCHEM (INDIA)
Back to Balance Sheet
|
SYSCHEM (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹124 Cr | ₹97 Cr | ₹43 Cr | ₹26 Cr | ₹41 Cr |
What is the latest Total Current Liabilities ratio of SYSCHEM (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹97 Cr |
| Mar2023 | ₹43 Cr |
| Mar2022 | ₹26 Cr |
| Mar2021 | ₹41 Cr |
How is Total Current Liabilities of SYSCHEM (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹124 Cr | 28.19 | |
| Mar2024 | ₹97 Cr | 125.18 | |
| Mar2023 | ₹43 Cr | 68.27 | |
| Mar2022 | ₹26 Cr | -37.54 | |
| Mar2021 | ₹41 Cr | - | |
Compare Total Current Liabilities of peers of SYSCHEM (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYSCHEM (INDIA) | ₹211.4 Cr | -4.9% | -12.8% | -2.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| CIPLA | ₹122,555.0 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
SYSCHEM (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYSCHEM (INDIA) | -4.9% |
-12.8% |
-2.2% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses